Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$621K Hold
4,833
0.25% 68
2026
Q1
$581K Sell
4,833
-405
-8% -$46.8K 0.25% 69
2025
Q4
$551K Buy
+5,238
New +$492K 0.24% 71
2025
Q2
$415K Sell
5,313
-30
-0.6% -$2.38K 0.19% 88
2025
Q1
$480K Sell
5,343
-342
-6% -$31.9K 0.23% 78
2024
Q4
$566K Hold
5,685
0.28% 68
2024
Q3
$646K Buy
5,685
+35
+0.6% +$4.16K 0.32% 66
2024
Q2
$699K Hold
5,650
0.37% 59
2024
Q1
$746K Sell
5,650
-84
-1% -$10.4K 0.39% 62
2023
Q4
$625K Sell
5,734
-117
-2% -$12.1K 0.35% 66
2023
Q3
$602K Buy
5,851
+436
+8% +$47K 0.38% 64
2023
Q2
$577K Buy
+5,415
New +$615K 0.34% 68

Other funds holding MRK

Union Savings Bank's MRK Position: Q2 2026 in Review

Union Savings Bank held its Merck (MRK) position steady in Q2 2026 at 4,833 shares worth $621K. The position accounts for 0.25% of the portfolio, ranked #68.

Union Savings Bank first reported a position in MRK in Q2 2023 and has held it in 12 quarters since. The position peaked at $746K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Union Savings Bank held 4,833 shares of Merck worth $621K as of Q2 2026.
  • Union Savings Bank left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.25% of Union Savings Bank's portfolio in Q2 2026, its #68 holding.
  • Union Savings Bank first reported a position in Merck in Q2 2023 and has held it in 12 quarters since.
  • Union Savings Bank's Merck position peaked at $746K in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Union Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.